New Service Helps Customers to Treat More Patients SUNNYVALE, Calif., Jan. 24 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the company will begin offering a treatment planning service to new and existing
SUNNYVALE, Calif. , Oct. 21, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY), today announced preliminary financial results for the first quarter of fiscal 2022 ended September 30, 2021 . Accuray is currently finalizing its financial results for the first quarter of fiscal 2022.
Q4 Revenue Expected to be Approximately $111.5-$112 Million and Q4 Gross Orders Expected to be Approximately $86 Million; Accuray Expects to Finish Fiscal Year with Approximately $108 Million in Cash, Cash Equivalents & Investments Preliminary Revenue and Product Order Results for Fourth
Conference Call at 5:00 p.m. EST Today SUNNYVALE, Calif. , Jan. 3, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today preliminary results for the second quarter of fiscal 2013 that ended December 31, 2012 and updated guidance for fiscal 2013.
Revenue Expected to be Approximately $107.5 Million; Gross Orders Expected to be Approximately $67 Million Management Reiterates Guidance for FY2016 SUNNYVALE, Calif. , Jan. 11, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today preliminary product orders and revenues for the
SUNNYVALE, Calif. , June 22, 2021 /PRNewswire/ -- Accuray (NASDAQ: ARAY) announced today that Suzanne Winter has been promoted to president, effective as of July 1, 2021 . Ms. Winter , who previously served as the company's chief commercial officer and senior vice president of R&D and medical and
SUNNYVALE, Calif., July 26, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY) ("Accuray") today announced its intention to commence an offering, subject to market and other conditions, of $75 million aggregate principal amount of convertible senior notes due 2016 (the "notes"), to
SUNNYVALE, Calif. , Feb. 6, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) (" Accuray ") today announced its intention to commence an offering, subject to market and other conditions, of $75 million aggregate principal amount of convertible senior notes due 2018 (the "notes"), to be
Key Milestone Reached with More Than 100 Systems Now in Use Worldwide SUNNYVALE, Calif., Oct. 26, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today significant momentum in global adoption of its TomoDirect treatment modality
New Organization Drives Focus on Sales and Revenue Growth SUNNYVALE, Calif., Oct 21, 2009 /PRNewswire-FirstCall via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today plans to establish an America's region thereby establishing regionalized
*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.
